Wordt geladen...
Pharmacogenomics as a risk mitigation strategy for chemotherapeutic cardiotoxicity
Damage to the heart can result from both traditional chemotherapeutic agents, such as doxorubicin, and newer ‘targeted’ therapies, such as trastuzumab. This chemotherapeutic cardiotoxicity is potentially life-threatening and necessitates limiting or discontinuing an otherwise-effective cancer treatm...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3582022/ https://ncbi.nlm.nih.gov/pubmed/23327580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs.12.205 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|